BACKGROUND AND OBJECTIVE: Use of oral erythromycin in infants is associated with infantile hypertrophic pyloric stenosis (IHPS). The risk with azithromycin remains unknown. We evaluated the association between exposure to oral azithromycin and erythromycin and subsequent development of IHPS. METHODS: A retrospective cohort study of children born between 2001 and 2012 was performed utilizing the military health system database. Infants prescribed either oral erythromycin or azithromycin as outpatients in the first 90 days of life were evaluated for development of IHPS. Specific diagnostic and procedural codes were used to identify cases of IHPS. RESULTS: A total of 2466 of 1 074 236 children in the study period developed IHPS. Azithromycin exposure in the first 14 days of life demonstrated an increased risk of IHPS (adjusted odds ratio [aOR], 8.26; 95% confidence interval [CI], 2.62–26.0); exposure between 15 and 42 days had an aOR of 2.98 (95% CI, 1.24–7.20). An association between erythromycin and IHPS was also confirmed. Exposure to erythromycin in the first 14 days of life had an aOR of 13.3 (95% CI, 6.80–25.9), and 15 to 42 days of life, aOR 4.10 (95% CI, 1.69–9.91). There was no association with either macrolide between 43 and 90 days of life. CONCLUSIONS: Ingestion of oral azithromycin and erythromycin places young infants at increased risk of developing IHPS. This association is strongest if the exposure occurred in the first 2 weeks of life, but persists although to a lesser degree in children between 2 and 6 weeks of age.
Background/Objectives: Invasive Streptococcus pneumoniae disease (IPD) and invasive Haemophilus influenzae (IHI) infections cause disease in pediatric patients. The COVID-19 pandemic brought about a change in the rates of common viral illnesses that can lead to superimposed bacterial infections. Methods: A repeated monthly cross-sectional study was performed using inpatient data from the Military Health System Data Repository (MDR) to observe differences in IPD and IHI hospitalization rates before and during the COVID-19 pandemic starting in March 2018 and continuing to February 2023. Our study included a cohort of 1.27 million children under the age of 5 years old. Results: A total of 200 unique cases of IPD and 171 unique cases of IHI were identified. In Year 1 of the pandemic, the hospitalization rates for IHI and IPD decreased. In Year 2, IPD returned to the pre-pandemic baseline, and IHI remained below the baseline. In Year 3, IPD increased above the baseline, and IHI returned to the baseline. Conclusions: These data support the notion that the interventions implemented to reduce the spread of COVID-19, such as hand hygiene and social distancing, likely led to a reduction in the incidence of invasive disease. The subsequent relaxation of these mitigation strategies likely led to a resurgence of IHI and an increase in IPD in our population.
To identify whether a relationship exists between COVID-19 and appendicitis and compare the incidence of appendicitis during three pandemic years to the year prior to the pandemic, we conducted two observational retrospective studies: a propensity score-matched (PSM) cohort and a repeated monthly cross-sectional study. We used data from the Military Health System (MHS) Data Repository, which contains data about healthcare provided to active-duty service members, retirees, and their dependents. For the PSM cohort of 753,138 individuals, patients with COVID-19 between July 2020 and June 2021 from the MHS were matched to two similar people without COVID-19. Survival analysis using a conditional Cox proportional hazards model explored these relationships. For the cross-sectional study we used a separate, unmatched MHS cohort of 10,402,021 individuals. Poisson regression generated incident rate ratios (IRRs) of any appendicitis or complicated appendicitis by year, comparing three pandemic years to one pre-pandemic year. COVID-19 was associated with appendicitis or appendectomy within the first year of infection (hazard ratio: 1.13, 95% confidence interval: 1.02–1.26). The IRRs for both any appendicitis and complicated appendicitis were significantly less than one when comparing individual pandemic years to the pre-pandemic year. COVID-19 is associated with appendicitis. Rates of any appendicitis and complicated appendicitis were lower in each individual pandemic year.